In 2024, the actual insurance revenue-expenditure surplus for the National Health Insurance (NHI) was NT$23.402 billion. In the same year, the NHI Administration had originally estimated a deficit of -NT$1.787 billion. 1
The difference between the two is NT$25.189 billion. The cumulative safety reserve balance stands at NT$162.2 billion, equivalent to 2.40 months of insurance benefit expenditures. 1
A Surplus of Exactly Twenty-Three Billion
Let's look at the three-year trend. The actual surpluses were NT$11.273 billion in 2022, NT$33.872 billion in 2023, and NT$23.402 billion in 2024. 1
The estimates tell a different story: -NT$32.308 billion, -NT$8.923 billion, and -NT$1.787 billion. The differences were NT$43.581 billion, NT$42.795 billion, and NT$25.189 billion, respectively. 1
In all three years, the "actual was better than estimated." This does not mean the NHI is making a profit; rather, it means the estimation models were conservative, and actual revenue exceeded expectations.
Why Estimates Were Inaccurate
The first reason listed in the report is supplementary insurance premiums. Revenue from supplementary premiums is heavily influenced by economic conditions. Lacking reliable leading indicators, the NHI Administration adopted a conservative principle, assuming a return to past growth trends; as a result, actual figures were lower than estimates for three consecutive years. 1
The second reason is wage adjustments. The minimum wage rose from NT$25,250 to NT$26,400, and then to NT$27,470; additionally, compensation for military, civil servants, and teachers was increased by 4%. These changes caused general premium revenue to exceed estimates. 1
The third reason is the return of the population. Explanations from 2023 pointed out that the return of the population following the easing of the pandemic occurred earlier than originally estimated, meaning the number of insured persons had been underestimated. 1
The raw variance rates look alarming: -134.89%, -479.60%, and -1,409.95%. However, the -1,409.95% in 2024 is a "denominator effect," because the estimated deficit was only -NT$1.787 billion; dividing the difference by such a small denominator amplifies the percentage. 1
Excluding unexpected factors, the variance rates for the three years were 3.54%, 0.94%, and 5.49%. 1
Two Point Four Months
The legal standard for safety reserves is written in Article 78 of the National Health Insurance Act: as a principle, it should be equivalent to 1 to 3 months of recent insurance benefit expenditures. 1
In 2022, total safety reserves were NT$104.9 billion (1.68 months); in 2023, NT$138.8 billion (2.14 months); and in 2024, NT$162.2 billion (2.40 months). 1
| 2022 | 1.68 | Cumulative balance: NT$104.9 billion |
|---|---|---|
| 2023 | 2.14 | 138.8 |
| 2024 | 2.4 | 162.213 |
Source: NHI Board "2024 National Health Insurance Supervisory Indicator Monitoring Report," Indicator 5.2
The 2.40 months falls within the legal range and is increasing annually. The report's commentary describes the "NHI finances as stable," but also warns to monitor the balance of the revenue-expenditure structure. 1
Consecutive Subsidies
The reason safety reserves have been able to rise is not entirely due to natural revenue growth. The report lists a series of injections since 2023. 1
In 2023, to address insufficient safety reserves, the Executive Yuan provided a NT$24 billion subsidy to the National Health Insurance Fund. In 2024, the Legislative Yuan passed a post-pandemic special budget, providing a NT$20 billion subsidy. 1
In 2025, the Executive Yuan proposed an NHI financial assistance plan: restricting the scope of "government-borne NHI premiums" to those specified under the NHI Act, which increases government subsidies by NT$13.4 billion; simultaneously, several public health and preventive care programs within the total amount were moved out to be covered by the general government budget. 1
A special ordinance announced on August 1 of the same year is expected to inject another NT$20 billion. 1
These amounts belong to different budgetary processes and cannot be summed into a single "total subsidy"; they are listed together to clarify the temporal overlap between the "rise in safety reserves" and "government capital injections."
Three Point Three Seven Percent of GDP
Another frequently cited figure is the ratio of NHI expenditure to GDP.
Including copayments: 3.48% in 2022, 3.48% in 2023, and 3.37% in 2024. Excluding copayments: 3.30%, 3.27%, and 3.17%. 1
The difference between the two is the copayment ratio: 0.18%, 0.21%, and 0.20%. The report suggests that the increase in 2023 may be related to the new outpatient medication and emergency room copayment system implemented on July 1 of that year. 1
The decline in the ratio does not mean spending has decreased. The report explains that because the GDP growth rate was higher than the total expenditure growth rate (in 2024, GDP grew by 8.459% while total expenditure grew by 4.700%), the denominator increased, causing the ratio to naturally decline. 1
The report notes in its data sources that the 2024 National Health Insurance medical expenditure data has not yet been released; therefore, the figures above are based on the total settlement values listed in the report. 1
International Coordinates
If comparing internationally, one must use a different indicator: Current Healthcare Expenditure (CHE) as a percentage of GDP.
From 2021 to 2023, Taiwan's shares were 7.1%, 7.3%, and 7.3%, which are lower than South Korea's 9.9%, Japan's 11.1%, and Germany's 11.8%, as well as the listed average of 10.4%. 1
Source: NHI Board report, citing Ministry of Health and Welfare Statistics Office "2023 National Healthcare Expenditure"
Another perspective is the public sector share. Taiwan's public sector CHE accounted for 60.3% of total CHE in 2023, lower than Canada's 70.5%, Germany's 85.9%, and Japan's 85.9%. 1
In other words, Taiwan's total healthcare expenditure as a percentage of GDP is relatively low, and the proportion borne by the public sector is also relatively low, which implies that the private sector (including out-of-pocket household expenses and commercial insurance) bears a relatively higher burden.
How to Read These Three Tables
The first table describes cash flow. The surplus is positive because revenue (including supplementary premiums and wage growth) exceeded expenditures, not because of premium hikes.
The second table describes the buffer. 2.40 months is within the legal range, but this number also includes the effect of government subsidies; reading it solely as "financial health" overlooks the contribution of government injections.
The third table describes scale. NHI expenditure at 3.37% of GDP and CHE at 7.3% of GDP are two different indicators: the former only counts NHI, while the latter includes out-of-pocket expenses and other sources. Comparing 3.37% to another country's 11% would lead to a false conclusion. 1
Taken together, these three numbers represent the current financial position of this system: there is no immediate crisis in revenue and expenditure, safety reserves are within range, but the structure still relies on government injections and wage growth for support.
Further Reading:
- Taiwan's Healthcare and National Health Insurance — System history, rates, and the other side of point values
- Emergency Room Congestion — How global budgets and payments reflect patient flow
- Average Life Expectancy in Taiwan — Demographic structure as the longest-term variable for NHI expenditure
References
- 2024 National Health Insurance Supervisory Indicator Monitoring Report (National Health Insurance Board, Ministry of Health and Welfare, November 2025) — Indicator 5.1 states the actual revenue-expenditure surplus for 2022–2024 (NT$11.273, NT$33.872, NT$23.402 billion) and estimates ( -NT$32.308, -NT$8.923, -NT$1.787 billion) along with variance rates; Indicator 5.2 states total safety reserves (NT$104.9, NT$138.8, NT$162.2 billion) and equivalent months (1.68, 2.14, 2.40 months) as well as annual subsidies; Indicator 5.3 states the ratio of NHI expenditure to GDP (including copayments: 3.48%, 3.48%, 3.37%; excluding copayments: 3.30%, 3.27%, 3.17%) and international comparisons of Current Healthcare Expenditure (Taiwan 7.3%, South Korea 9.9%, Japan 11.1%, Germany 11.8%, Average 10.4%).↩234567891011121314151617181920212223